← Open Payments lookup

YUN JI KANG: Open Payments

NPI 1700509312 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$631 in 30 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $401 · 2025 $631

Food & beverage: $631
CompanyPaymentsAmount
Novo Nordisk Inc5$135
GlaxoSmithKline, LLC.5$118
PFIZER INC.5$98
ABBVIE INC.5$92
AstraZeneca Pharmaceuticals LP4$81
Lilly USA, LLC2$51
Phadia US Inc.1$23
Astellas Pharma US Inc1$17
Phathom Pharmaceuticals, Inc.2$16

Products named: TRELEGY ELLIPTA, AIRSUPRA, Wegovy, ELIQUIS, Ozempic, UBRELVY, ZEPBOUND, VIBERZI.

Industry payments across DC — which companies pay providers there.